Reata CEO on positive trial results for drug to treat Friedreich's ataxia

Warren Huff, Reata Pharma CEO, joins CNBC's "Power Lunch" team to discuss his company's positive clinical trial results for a drug to treat the neuromuscular disease Friedreich's ataxia.
03:42
Fri, Oct 18 20196:45 PM EST